Handheld COVID-19 Disinfecting Wand Kills 99.9% of SARS-CoV-2 in 10 Seconds

By HospiMedica International staff writers
Posted on 10 Dec 2020
A new handheld disinfecting wand against SARS-CoV-2 (COVID-19) has passed validation testing by achieving a confirmed >99.97% level of disinfection in 10 seconds.

The Acuva SOLARIX handheld disinfecting wand against SARS-CoV-2 developed by Acuva Technologies Inc. (Burnaby, BC, Canada) is a portable and rechargeable UV-LED disinfection device that fits in the pocket. It delivers powerful chemical-free disinfection performance which achieves an efficacy rate of >99.9% against viruses and bacteria, including all coronaviruses. Using the SOLARIX device, users can safely disinfect high-touch non-porous surfaces. Featuring high-intensity germicidal UV energy, the device is designed for efficacy, portability, safety and ease of use. Its battery charges with a common USB-C cable so users can easily connect it to any USB port to recharge.

Image: The Acuva™ SOLARIX handheld disinfecting wand (Photo courtesy of Acuva Technologies Inc.)

The SOLARIX includes a number of features to ensure safe operation, including visible blue light mapping to indicate the area being disinfected. It opens to a wide 270-degree angle to allow for faster and easier disinfection of contoured and difficult to reach surfaces, in comparison to typical sanitizing practices and cleaning solutions. A built-in sensor prevents any accidental user hand exposure to UV. It also includes a built-in timer and a power button that requires double-click activation as a child-lock function.

"My personal ordeal with COVID-19 earlier this year gave me time to think about others facing this ruthless virus," said Manoj Singh, CEO of Acuva. "We decided to join the fight against COVID-19 by doing what we do best. We applied the same key principles used in our signature approach to UV-LED disinfection system design towards the creation of new products to help mitigate the spread of the virus."

Related Links:
Acuva Technologies Inc.


Latest COVID-19 News